Sign In
NASDAQ:FBIO
Fortress Biotech Stock Earnings Reports
$1.72
+0.0100 (+0.585%)
At Close: Mar 24, 2025
Fortress Biotech Earnings Calls
Q4 2024
(Upcoming)
| Release date | Mar 27, 2025 |
| EPS estimate | -$0.750 |
| EPS actual | - |
| Revenue estimate | 16.297M |
| Revenue actual | - |
| Expected change | +/- 8.69% |
Q3 2024
Missed
-$0.760 (-181.48%)
| Release date | Nov 14, 2024 |
| EPS estimate | -$0.270 |
| EPS actual | -$0.760 |
| EPS Surprise | -181.48% |
| Revenue estimate | 15.576M |
| Revenue actual | 14.629M |
| Revenue Surprise | -6.08% |
Q2 2024
Beat
-$0.730 (44.70%)
| Release date | Aug 13, 2024 |
| EPS estimate | -$1.32 |
| EPS actual | -$0.730 |
| EPS Surprise | 44.70% |
| Revenue estimate | 14.77M |
| Revenue actual | 14.896M |
| Revenue Surprise | 0.85% |
Q1 2024
Beat
-$1.03 (49.26%)
| Release date | May 15, 2024 |
| EPS estimate | -$2.03 |
| EPS actual | -$1.03 |
| EPS Surprise | 49.26% |
| Revenue estimate | 14.13M |
| Revenue actual | 13.03M |
| Revenue Surprise | -7.78% |
Last 4 Quarters for Fortress Biotech
Below you can see how FBIO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Q1 2024
Beat
| Release date | May 15, 2024 |
| Fiscal end date | Mar 31, 2024 |
| Price on release | $1.74 |
| EPS estimate | -$2.03 |
| EPS actual | -$1.03 |
| EPS surprise | 49.26% |
| Date | Price |
|---|---|
| May 09, 2024 | $1.71 |
| May 10, 2024 | $1.67 |
| May 13, 2024 | $1.70 |
| May 14, 2024 | $1.76 |
| May 15, 2024 | $1.74 |
| May 16, 2024 | $1.76 |
| May 17, 2024 | $1.93 |
| May 20, 2024 | $1.95 |
| May 21, 2024 | $1.98 |
| 4 days before | 1.75% |
| 4 days after | 13.79% |
| On release day | 1.15% |
| Change in period | 15.79% |
Q2 2024
Beat
| Release date | Aug 13, 2024 |
| Fiscal end date | Jun 30, 2024 |
| Price on release | $1.83 |
| EPS estimate | -$1.32 |
| EPS actual | -$0.730 |
| EPS surprise | 44.70% |
| Date | Price |
|---|---|
| Aug 07, 2024 | $1.73 |
| Aug 08, 2024 | $1.87 |
| Aug 09, 2024 | $1.83 |
| Aug 12, 2024 | $1.77 |
| Aug 13, 2024 | $1.83 |
| Aug 14, 2024 | $1.81 |
| Aug 15, 2024 | $1.90 |
| Aug 16, 2024 | $1.86 |
| Aug 19, 2024 | $1.94 |
| 4 days before | 5.78% |
| 4 days after | 6.01% |
| On release day | -1.09% |
| Change in period | 12.14% |
Q3 2024
Missed
| Release date | Nov 14, 2024 |
| Fiscal end date | Sep 30, 2024 |
| Price on release | $1.57 |
| EPS estimate | -$0.270 |
| EPS actual | -$0.760 |
| EPS surprise | -181.48% |
| Date | Price |
|---|---|
| Nov 08, 2024 | $1.71 |
| Nov 11, 2024 | $1.76 |
| Nov 12, 2024 | $1.70 |
| Nov 13, 2024 | $1.65 |
| Nov 14, 2024 | $1.57 |
| Nov 15, 2024 | $1.43 |
| Nov 18, 2024 | $1.48 |
| Nov 19, 2024 | $1.59 |
| Nov 20, 2024 | $1.57 |
| 4 days before | -8.19% |
| 4 days after | 0% |
| On release day | -8.92% |
| Change in period | -8.19% |
Q4 2024
(Upcoming)
| Release date | Mar 27, 2025 |
| Fiscal end date | Dec 30, 2024 |
| Price on release | - |
| EPS estimate | -$0.750 |
| EPS actual | - |
| Date | Price |
|---|---|
| Mar 18, 2025 | $1.72 |
| Mar 19, 2025 | $1.72 |
| Mar 20, 2025 | $1.70 |
| Mar 21, 2025 | $1.71 |
| Mar 24, 2025 | $1.72 |
Fortress Biotech Earnings History
Earnings Calendar
FAQ
When is the earnings report for FBIO?
Fortress Biotech (FBIO) has scheduled its earnings report for Mar 27, 2025 before the markets open.
What is the FBIO price-to-earnings (P/E) ratio?
FBIO P/E ratio as of Mar 24, 2025 (TTM) is -0.663.
What is the FBIO EPS forecast?
The forecasted EPS (Earnings Per Share) for Fortress Biotech (FBIO) for the first fiscal quarter 2024 is -$0.750.
What are Fortress Biotech's retained earnings?
On its balance sheet, Fortress Biotech reported retained earnings of $14.63 million for the latest quarter ending Sep 30, 2024.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
